These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22814582)

  • 1. Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.
    Zhang YQ; Pilyugin M; Kuester D; Leoni VP; Li L; Casula G; Zorcolo L; Schneider-Stock R; Atzori L; Irminger-Finger I
    Br J Cancer; 2012 Aug; 107(4):675-83. PubMed ID: 22814582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BARD1: an independent predictor of survival in non-small cell lung cancer.
    Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
    Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BARD1 expression predicts outcome in colon cancer.
    Sporn JC; Hothorn T; Jung B
    Clin Cancer Res; 2011 Aug; 17(16):5451-62. PubMed ID: 21693656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
    Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues.
    Lombardi G; Falaschi E; Di Cristofano C; Naccarato AG; Sensi E; Aretini P; Roncella M; Bevilacqua G; Caligo MA
    Genes Chromosomes Cancer; 2007 Sep; 46(9):791-5. PubMed ID: 17497650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
    Dizin E; Irminger-Finger I
    Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1 and BARD1 colocalize mainly in the cytoplasm of breast cancer tumors, and their isoforms show differential expression.
    Wiener D; Gajardo-Meneses P; Ortega-Hernández V; Herrera-Cares C; Díaz S; Fernández W; Cornejo V; Gamboa J; Tapia T; Alvarez C; Carvallo P
    Breast Cancer Res Treat; 2015 Oct; 153(3):669-78. PubMed ID: 26395808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer.
    Ozden O; Bishehsari F; Bauer J; Park SH; Jana A; Baik SH; Sporn JC; Staudacher JJ; Yazici C; Krett N; Jung B
    Sci Rep; 2016 May; 6():26273. PubMed ID: 27197561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2.
    Ryser S; Dizin E; Jefford CE; Delaval B; Gagos S; Christodoulidou A; Krause KH; Birnbaum D; Irminger-Finger I
    Cancer Res; 2009 Feb; 69(3):1125-34. PubMed ID: 19176389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BARD1 mediates TGF-β signaling in pulmonary fibrosis.
    André PA; Prêle CM; Vierkotten S; Carnesecchi S; Donati Y; Chambers RC; Pache JC; Crestani B; Barazzone-Argiroffo C; Königshoff M; Laurent GJ; Irminger-Finger I
    Respir Res; 2015 Sep; 16():118. PubMed ID: 26415510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
    Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
    Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
    Pilyugin M; Irminger-Finger I
    Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts on BARD1: Regulator of BRCA pathways and beyond.
    Irminger-Finger I; Ratajska M; Pilyugin M
    Int J Biochem Cell Biol; 2016 Mar; 72():1-17. PubMed ID: 26738429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women.
    Śniadecki M; Brzeziński M; Darecka K; Klasa-Mazurkiewicz D; Poniewierza P; Krzeszowiec M; Kmieć N; Wydra D
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
    Liao Y; Yuan S; Chen X; Zhu P; Li J; Qin L; Liao W
    Sci Rep; 2017 Aug; 7(1):7649. PubMed ID: 28794477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.
    Pilyugin M; André PA; Ratajska M; Kuzniacka A; Limon J; Tournier BB; Colas J; Laurent G; Irminger-Finger I
    Oncotarget; 2017 Feb; 8(6):9339-9353. PubMed ID: 28030839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms.
    Ratajska M; Matusiak M; Kuzniacka A; Wasag B; Brozek I; Biernat W; Koczkowska M; Debniak J; Sniadecki M; Kozlowski P; Klonowska K; Pilyugin M; Wydra D; Laurent G; Limon J; Irminger-Finger I
    Oncol Rep; 2015 Nov; 34(5):2609-17. PubMed ID: 26329992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BARD1 mystery: tumor suppressors are cancer susceptibility genes.
    Hawsawi YM; Shams A; Theyab A; Abdali WA; Hussien NA; Alatwi HE; Alzahrani OR; Oyouni AAA; Babalghith AO; Alreshidi M
    BMC Cancer; 2022 Jun; 22(1):599. PubMed ID: 35650591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mRNA Processing Factor CstF-50 and Ubiquitin Escort Factor p97 Are BRCA1/BARD1 Cofactors Involved in Chromatin Remodeling during the DNA Damage Response.
    Fonseca D; Baquero J; Murphy MR; Aruggoda G; Varriano S; Sapienza C; Mashadova O; Rahman S; Kleiman FE
    Mol Cell Biol; 2018 Feb; 38(4):. PubMed ID: 29180510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.